Investing.com - Hologic (NASDAQ: HOLX) reported fourth quarter EPS of $1.01, in line with the analyst estimate of $1.01. Revenue for the quarter came in at $987.9M versus the consensus estimate of $978.27M.
Guidance
Hologic sees Q1 2025 EPS of $1.00-$1.03 versus the analyst consensus of $1.03.
Hologic's stock price closed at $83.72. It is up 0.40% in the last 3 months and up 21.92% in the last 12 months.
Hologic saw 0 positive EPS revisions and 12 negative EPS revisions in the last 90 days. See Hologic's stock price’s past reactions to earnings here.
According to InvestingPro, Hologic's Financial Health score is "great performance".
Check out Hologic's recent earnings performance, and Hologic's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar